Human Salmonella clinical isolates distinct from those of animal origin

Douglas M. Heithoff, William R. Shimp, Patrick W. Lau, Golnaz Badie, Elena Y. Enioutina, Raymond A. Daynes, Barbara A Byrne, John K. House, Michael J. Mahan

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

The global trend toward intensive livestock production has led to significant public health risks and industry-associated losses due to an increased incidence of disease and contamination of livestock-derived food products. A potential factor contributing to these health concerns is the prospect that selective pressure within a particular host may give rise to bacterial strain variants that exhibit enhanced fitness in the present host relative to that in the parental host from which the strain was derived. Here, we assessed 184 Salmonella enterica human and animal clinical isolates for their virulence capacities in mice and for the presence of the Salmonella virulence plasmid encoding the SpvB actin cytotoxin required for systemic survival and Pef fimbriae, implicated in adherence to the murine intestinal epithelium. All (21 of 21) serovar Typhimurium clinical isolates derived from animals were virulent in mice, whereas many (16 of 41) serovar Typhimurium isolates derived from human salmonellosis patients lacked this capacity. Additionally, many (10 of 29) serovar Typhimurium isolates derived from gastroenteritis patients did not possess the Salmonella virulence plasmid, in contrast to all animal and human bacteremia isolates tested. Lastly, among serovar Typhimurium isolates that harbored the Salmonella virulence plasmid, 6 of 31 derived from human salmonellosis patients were avirulent in mice, which is in contrast to the virulent phenotype exhibited by all the animal isolates examined. These studies suggest that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal origin. The characterization of these bacterial strain variants may provide insight into their relative pathogenicities as well as into the development of treatment and prophylactic strategies for salmonellosis.

Original languageEnglish (US)
Pages (from-to)1757-1766
Number of pages10
JournalApplied and Environmental Microbiology
Volume74
Issue number6
DOIs
StatePublished - Mar 2008

Fingerprint

Salmonella
Salmonella Infections
Virulence
salmonellosis
virulence
serotypes
plasmid
animal
plasmids
Plasmids
mice
Livestock
animals
gastroenteritis
cytotoxins
bacteremia
Salmonella enterica
fimbriae
livestock farming
Cytotoxins

ASJC Scopus subject areas

  • Environmental Science(all)
  • Biotechnology
  • Microbiology

Cite this

Heithoff, D. M., Shimp, W. R., Lau, P. W., Badie, G., Enioutina, E. Y., Daynes, R. A., ... Mahan, M. J. (2008). Human Salmonella clinical isolates distinct from those of animal origin. Applied and Environmental Microbiology, 74(6), 1757-1766. https://doi.org/10.1128/AEM.02740-07

Human Salmonella clinical isolates distinct from those of animal origin. / Heithoff, Douglas M.; Shimp, William R.; Lau, Patrick W.; Badie, Golnaz; Enioutina, Elena Y.; Daynes, Raymond A.; Byrne, Barbara A; House, John K.; Mahan, Michael J.

In: Applied and Environmental Microbiology, Vol. 74, No. 6, 03.2008, p. 1757-1766.

Research output: Contribution to journalArticle

Heithoff, DM, Shimp, WR, Lau, PW, Badie, G, Enioutina, EY, Daynes, RA, Byrne, BA, House, JK & Mahan, MJ 2008, 'Human Salmonella clinical isolates distinct from those of animal origin', Applied and Environmental Microbiology, vol. 74, no. 6, pp. 1757-1766. https://doi.org/10.1128/AEM.02740-07
Heithoff DM, Shimp WR, Lau PW, Badie G, Enioutina EY, Daynes RA et al. Human Salmonella clinical isolates distinct from those of animal origin. Applied and Environmental Microbiology. 2008 Mar;74(6):1757-1766. https://doi.org/10.1128/AEM.02740-07
Heithoff, Douglas M. ; Shimp, William R. ; Lau, Patrick W. ; Badie, Golnaz ; Enioutina, Elena Y. ; Daynes, Raymond A. ; Byrne, Barbara A ; House, John K. ; Mahan, Michael J. / Human Salmonella clinical isolates distinct from those of animal origin. In: Applied and Environmental Microbiology. 2008 ; Vol. 74, No. 6. pp. 1757-1766.
@article{80115a9bff8d4601983424e270df12d0,
title = "Human Salmonella clinical isolates distinct from those of animal origin",
abstract = "The global trend toward intensive livestock production has led to significant public health risks and industry-associated losses due to an increased incidence of disease and contamination of livestock-derived food products. A potential factor contributing to these health concerns is the prospect that selective pressure within a particular host may give rise to bacterial strain variants that exhibit enhanced fitness in the present host relative to that in the parental host from which the strain was derived. Here, we assessed 184 Salmonella enterica human and animal clinical isolates for their virulence capacities in mice and for the presence of the Salmonella virulence plasmid encoding the SpvB actin cytotoxin required for systemic survival and Pef fimbriae, implicated in adherence to the murine intestinal epithelium. All (21 of 21) serovar Typhimurium clinical isolates derived from animals were virulent in mice, whereas many (16 of 41) serovar Typhimurium isolates derived from human salmonellosis patients lacked this capacity. Additionally, many (10 of 29) serovar Typhimurium isolates derived from gastroenteritis patients did not possess the Salmonella virulence plasmid, in contrast to all animal and human bacteremia isolates tested. Lastly, among serovar Typhimurium isolates that harbored the Salmonella virulence plasmid, 6 of 31 derived from human salmonellosis patients were avirulent in mice, which is in contrast to the virulent phenotype exhibited by all the animal isolates examined. These studies suggest that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal origin. The characterization of these bacterial strain variants may provide insight into their relative pathogenicities as well as into the development of treatment and prophylactic strategies for salmonellosis.",
author = "Heithoff, {Douglas M.} and Shimp, {William R.} and Lau, {Patrick W.} and Golnaz Badie and Enioutina, {Elena Y.} and Daynes, {Raymond A.} and Byrne, {Barbara A} and House, {John K.} and Mahan, {Michael J.}",
year = "2008",
month = "3",
doi = "10.1128/AEM.02740-07",
language = "English (US)",
volume = "74",
pages = "1757--1766",
journal = "Applied and Environmental Microbiology",
issn = "0099-2240",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Human Salmonella clinical isolates distinct from those of animal origin

AU - Heithoff, Douglas M.

AU - Shimp, William R.

AU - Lau, Patrick W.

AU - Badie, Golnaz

AU - Enioutina, Elena Y.

AU - Daynes, Raymond A.

AU - Byrne, Barbara A

AU - House, John K.

AU - Mahan, Michael J.

PY - 2008/3

Y1 - 2008/3

N2 - The global trend toward intensive livestock production has led to significant public health risks and industry-associated losses due to an increased incidence of disease and contamination of livestock-derived food products. A potential factor contributing to these health concerns is the prospect that selective pressure within a particular host may give rise to bacterial strain variants that exhibit enhanced fitness in the present host relative to that in the parental host from which the strain was derived. Here, we assessed 184 Salmonella enterica human and animal clinical isolates for their virulence capacities in mice and for the presence of the Salmonella virulence plasmid encoding the SpvB actin cytotoxin required for systemic survival and Pef fimbriae, implicated in adherence to the murine intestinal epithelium. All (21 of 21) serovar Typhimurium clinical isolates derived from animals were virulent in mice, whereas many (16 of 41) serovar Typhimurium isolates derived from human salmonellosis patients lacked this capacity. Additionally, many (10 of 29) serovar Typhimurium isolates derived from gastroenteritis patients did not possess the Salmonella virulence plasmid, in contrast to all animal and human bacteremia isolates tested. Lastly, among serovar Typhimurium isolates that harbored the Salmonella virulence plasmid, 6 of 31 derived from human salmonellosis patients were avirulent in mice, which is in contrast to the virulent phenotype exhibited by all the animal isolates examined. These studies suggest that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal origin. The characterization of these bacterial strain variants may provide insight into their relative pathogenicities as well as into the development of treatment and prophylactic strategies for salmonellosis.

AB - The global trend toward intensive livestock production has led to significant public health risks and industry-associated losses due to an increased incidence of disease and contamination of livestock-derived food products. A potential factor contributing to these health concerns is the prospect that selective pressure within a particular host may give rise to bacterial strain variants that exhibit enhanced fitness in the present host relative to that in the parental host from which the strain was derived. Here, we assessed 184 Salmonella enterica human and animal clinical isolates for their virulence capacities in mice and for the presence of the Salmonella virulence plasmid encoding the SpvB actin cytotoxin required for systemic survival and Pef fimbriae, implicated in adherence to the murine intestinal epithelium. All (21 of 21) serovar Typhimurium clinical isolates derived from animals were virulent in mice, whereas many (16 of 41) serovar Typhimurium isolates derived from human salmonellosis patients lacked this capacity. Additionally, many (10 of 29) serovar Typhimurium isolates derived from gastroenteritis patients did not possess the Salmonella virulence plasmid, in contrast to all animal and human bacteremia isolates tested. Lastly, among serovar Typhimurium isolates that harbored the Salmonella virulence plasmid, 6 of 31 derived from human salmonellosis patients were avirulent in mice, which is in contrast to the virulent phenotype exhibited by all the animal isolates examined. These studies suggest that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal origin. The characterization of these bacterial strain variants may provide insight into their relative pathogenicities as well as into the development of treatment and prophylactic strategies for salmonellosis.

UR - http://www.scopus.com/inward/record.url?scp=40849119817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849119817&partnerID=8YFLogxK

U2 - 10.1128/AEM.02740-07

DO - 10.1128/AEM.02740-07

M3 - Article

C2 - 18245251

AN - SCOPUS:40849119817

VL - 74

SP - 1757

EP - 1766

JO - Applied and Environmental Microbiology

JF - Applied and Environmental Microbiology

SN - 0099-2240

IS - 6

ER -